QTTB Q32 Bio Inc.

Price (delayed)

$14.21

Market cap

$240.95M

P/E Ratio

5.09

Dividend/share

N/A

EPS

$2.79

Enterprise value

$202.48M

?
Relative Growth: Rel. Growth: 49
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 96
Relative Profitability: Rel. Profitability: 99

homology medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.

Highlights
QTTB's EPS has soared by 157% YoY and by 15% from the previous quarter
QTTB's net income has surged by 156% year-on-year and by 11% since the previous quarter

Key stats

What are the main financial stats of QTTB

QTTB stock price

How has the Q32 Bio stock price performed over time
Intraday
16.57%
1 week
37.83%
1 month
181.94%
1 year
636.27%
YTD
328.01%
QTD
121.34%

Financial performance

How have Q32 Bio's revenue and profit performed over time
Revenue
$53.74M
Gross profit
$53.74M
Operating income
$21.41M
Net income
$33.24M
Gross margin
100%
Net margin
61.9%
QTTB's net income has surged by 156% year-on-year and by 11% since the previous quarter
The operating income has soared by 134% year-on-year and by 27% since the previous quarter
The operating margin has grown by 26% from the previous quarter
QTTB's net margin is up by 12% since the previous quarter

Price vs fundamentals

How does QTTB's price correlate with its fundamentals

Growth

What is Q32 Bio's growth rate over time

Valuation

What is Q32 Bio stock price valuation
P/E
5.09
P/B
4.49
P/S
3.73
EV/EBIT
6.09
EV/EBITDA
5.91
EV/Sales
3.77
QTTB's EPS has soared by 157% YoY and by 15% from the previous quarter
QTTB's equity is up by 10% since the previous quarter
The P/B is 10% above the 5-year quarterly average of 3.5

Efficiency

How efficient is Q32 Bio business performance
The ROA has soared by 189% YoY and by 18% from the previous quarter
Q32 Bio's return on invested capital has surged by 171% YoY and by 15% QoQ
The return on equity has surged by 152% year-on-year but it has dropped by 86% since the previous quarter
QTTB's ROS is up by 12% from the previous quarter

Dividends

What is QTTB's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QTTB.

Financial health

How did Q32 Bio financials performed over time
The total liabilities has plunged by 79% YoY and by 12% from the previous quarter
The total assets has declined by 19% year-on-year but it has grown by 3.1% since the previous quarter
QTTB's debt is 72% smaller than its equity
Q32 Bio's debt to equity has soared by 106% YoY but it has decreased by 20% from the previous quarter
QTTB's debt is down by 29% year-on-year and by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.